Esophageal cancer, gastric cancer, duodenal cancer, Biliary tract cancer, pancreatic cancer, colon cancer
Conditions
Interventions
Submucosal and subserosal injections of the ICG gastrointestinal tract
Sponsors
Osaka Medical and Pharmaceutical University, Department of General and Gastroenterological Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Gastrointestinal cancer patients (esophageal cancer, gastric cancer, duodenal cancer, biliary tract cancer, pancreatic cancer, and colorectal cancer) surgery undergoing elective surgery at our university
Exclusion criteria
Exclusion criteria: Patients with a history of hypersensitivity to ICG components
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of fluorescence images useful for determining the extent of excision | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of fluorescent images of lymphatic flow from the serosa of the organ to the base of the artery along the area of the dominant artery Negative margin rate in resected specimens Long-term results (relapse-free survival, overall survival) | — |
Countries
Japan
Contacts
Public ContactRyo Tanaka
Osaka Medical and Pharmaceutical University Department of General and Gastroenterological Surgery
Outcome results
None listed